biliary tract - HEALTHIES
New targeted therapies reshape biliary tract cancer care, highlighting FGFR2/IDH1, HER2 and KRAS options plus smarter second-line sequencing. In an interview with Targeted Oncology, Linda Y. Wu, MD, ...
Understanding the Context
Targeted Oncology: FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer The FDA has granted orphan drug Designation to tovecimig (CTX-009) for the treatment of patients with biliary tract cancer (BTC) according to Compass Therapeutics, the company developing the ... Monthly Prescribing Reference: Tovecimig Plus Paclitaxel Shows Promise in Advanced Biliary Tract Cancer MarketWatch: Phanes Therapeutics announces dose expansion in clinical study of spevatamig in combination with chemotherapy for treatment of biliary tract cancer Phanes Therapeutics announces dose expansion in clinical study of spevatamig in combination with chemotherapy for treatment of biliary tract cancer The American Journal of Managed Care: FDA Approves Zanidatamab-hrii for HER2+ Biliary Tract Cancer Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ... Yahoo Finance: Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary tract cancers, including cholangiocarcinoma and gallbladder carcinoma, represent a heterogeneous group of malignancies with rising global incidence and persistent dismal prognoses.
Image Gallery
Key Insights
Research in ... The US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) for locally advanced unresectable or metastatic biliary tract cancer in combination with gemcitabine and cisplatin. Acute cholangitis is a severe, bacterial infection of the biliary tract precipitated by an obstruction that often results in systemic inflammation and, in some cases, life‐threatening sepsis. This ... The FDA on Wednesday granted accelerated approval to zanidatamab (Ziihera), a bispecific antibody, for pretreated HER2-positive biliary tract cancer.
Related Articles You Might Like:
best protein foods for fat loss how many carbs should i consume healthy options at chick fil aFinal Thoughts
Approval stipulates use in unresectable or ...